Are HIV medicines reimbursed in the Russian Federation?

Home / Countries / Russian Federation / HIV medicines

Russian Federation · availability and reimbursement

HIV medicines in The Russian Federation

Of 26 verified HIV medicine records for the Russian Federation, 5 are available and reimbursed (19%), 3 are available but not reimbursed and 18 are not available. 12 further records are still under review.

19% of verified records reimbursed

Last checked 14/09/2026 · This is information only, not advice or a recommendation.

Medicines by status

Available and reimbursed 5

Generic TDF/FTC (Emtricitabine/Tenofovir DF), Generic TLD (Tenofovir/Lamivudine/Dolutegravir), Isentress, Kaletra, Tivicay

Available, not reimbursed 3

Biktarvy, Genvoya, Odefsey

Not available 18

Celsentri, Delstrigo, Descovy, Dovato, Edurant, Generic TLE (Tenofovir/Lamivudine/Efavirenz), Intelence, Juluca, Pifeltro, Prezista, Rekambys, Rukobia, Sunlenca, Symtuza, Triumeq, Truvada, Vocabria, Vocabria / Rekambys

Under review 12

Apretude, Emtriva, Epivir, Eviplera, Kivexa, Norvir, Retrovir, Rezolsta, Stribild, Viread, Yeytuo, Ziagen

See every medicine with its source →

More about the Russian Federation

PrEP DoxyPEP Sexuality education Abortion and contraception Migrant healthcare Full Russian Federation profile

Neighbouring countries

Ukraine Poland Norway Lithuania Latvia Kazakhstan Georgia Finland

Open the interactive map

Based on public, cited sources and SHAPE's review. Rules and prices change, so please confirm with the national authority or a professional. Found an error? Tell us.